RecruitingNot Applicable

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

United States1,500 participantsStarted 2024-03-07

Plain-language summary

Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.

Who can participate

Age range12 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Has ever been diagnosed with severe AA by a dermatologist or a qualified dermatology provider.
✓. Is 12-17 years of age at the time of enrollment.
✓. Is willing to provide consent/assent for participation in the registry.
✓. Has been prescribed a new commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents in the context of routine clinical care that is consistent with local prescribing guidelines and/or regulations for the country where the site is located.
✓. At the time of registry enrollment OR
✓. Within 6 months prior to registry enrollment In the opinion of the treating provider, is deemed a candidate for treatment with a commercially available advanced therapy and/or conventional systemic therapy for the treatment of severe AA in adolescents but has not received nor is planning to initiate treatment at the time of registry enrollment.

Exclusion criteria

✕. Is participating or planning to participate in a blinded clinical trial for any investigational medication.
✕. Is unwilling or unable to provide standing height measurements.

What they're measuring

AA epidemiology, presentation, natural history, management, and outcomes

Timeframe: Through Study completion until the subject is 18 years

Trial details

NCT IDNCT06562270

SponsorCorEvitas

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2099-12-31

Contact for this trial

CorEvitas

View on ClinicalTrials.gov More Alopecia Areata trials